Join Industry Change-makers
Anchor Partners
Anchor Partners
Anchor Partners
IAIRO’s PPP model is sponsored by IndiaAI mission, MeitY, Gujarat DST, and the Indian Pharma Association (inaugural members, will be expanded substantially).
Impressive metrics
Impressive metrics
Impressive metrics
Born from the collective ambition of industry veterans and technology innovators, our mission is to expedite the journey of groundbreaking healthcare solutions from conception to global markets.
Actionable insights into healthcare market trends and consumer needs.
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
Actionable insights into healthcare market trends and consumer needs.
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
Actionable insights into healthcare market trends and consumer needs.
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
Strategic partnerships between institutions, biotech companies, and investors.
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
Strategic partnerships between institutions, biotech companies, and investors.
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
Strategic partnerships between institutions, biotech companies, and investors.
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
Advice on compliance, regulatory processes, and market entry strategies
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
Advice on compliance, regulatory processes, and market entry strategies
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
Advice on compliance, regulatory processes, and market entry strategies
Frontier AI for drug discovery, genomics, and molecular simulation. IAIRO collaborates with leading pharma alliances, bioinformatics researchers, and public institutions to accelerate discovery, shorten R&D cycles, and strengthen India’s life sciences ecosystem — from early discovery to translational research and regulatory-aware deployment.
* Add any required disclaimer text for the claims made above using this small fine-print text.
Our Process
Our Process
Our Process
01
Discovery and Assessment
The journey begins with proactive search for promising medical research projects. Our team conducts a thorough assessment, evaluating each project's innovation, potential impact, and feasibility. This involves rigorous scientific review, potential market analysis, and preliminary discussions with research teams to understand their vision, capabilities, and needs.
01
Discovery and Assessment
The journey begins with proactive search for promising medical research projects. Our team conducts a thorough assessment, evaluating each project's innovation, potential impact, and feasibility. This involves rigorous scientific review, potential market analysis, and preliminary discussions with research teams to understand their vision, capabilities, and needs.
01
Discovery and Assessment
The journey begins with proactive search for promising medical research projects. Our team conducts a thorough assessment, evaluating each project's innovation, potential impact, and feasibility. This involves rigorous scientific review, potential market analysis, and preliminary discussions with research teams to understand their vision, capabilities, and needs.
02
Due Diligence and Selection
Following initial assessments, selected projects undergo a comprehensive due diligence process. This step digs deeper into the project's technical details, team qualifications, legal considerations, and financial requirements. It ensures that only the most viable and impactful projects are chosen for funding, aligning with Stem's mission to accelerate the development of transformative healthcare solutions.
02
Due Diligence and Selection
Following initial assessments, selected projects undergo a comprehensive due diligence process. This step digs deeper into the project's technical details, team qualifications, legal considerations, and financial requirements. It ensures that only the most viable and impactful projects are chosen for funding, aligning with Stem's mission to accelerate the development of transformative healthcare solutions.
02
Due Diligence and Selection
Following initial assessments, selected projects undergo a comprehensive due diligence process. This step digs deeper into the project's technical details, team qualifications, legal considerations, and financial requirements. It ensures that only the most viable and impactful projects are chosen for funding, aligning with Stem's mission to accelerate the development of transformative healthcare solutions.
03
Matching with Investors
Once a project passes our stringent evaluation process, Stem matches it with suitable investors from our network. This matchmaking is based on the project's specific needs and the investor's interest areas and investment philosophy. Our aim is to create synergistic partnerships that provide not just financial support but also strategic value to propel the research forward.
03
Matching with Investors
Once a project passes our stringent evaluation process, Stem matches it with suitable investors from our network. This matchmaking is based on the project's specific needs and the investor's interest areas and investment philosophy. Our aim is to create synergistic partnerships that provide not just financial support but also strategic value to propel the research forward.
03
Matching with Investors
Once a project passes our stringent evaluation process, Stem matches it with suitable investors from our network. This matchmaking is based on the project's specific needs and the investor's interest areas and investment philosophy. Our aim is to create synergistic partnerships that provide not just financial support but also strategic value to propel the research forward.
Client Experience
Client Experience
Client Experience
“Working with Stem has been a transformative experience. They occupy the impossible space between medical research and responsible capitalism.”
David Kahn
Chief Executive Officer
“Working with Stem has been a transformative experience. They occupy the impossible space between medical research and responsible capitalism.”
David Kahn
Chief Executive Officer
“Working with Stem has been a transformative experience. They occupy the impossible space between medical research and responsible capitalism.”
David Kahn
Chief Executive Officer
Strategic partnerships between institutions, biotech companies, and investors.
Strategic partnerships between institutions, biotech companies, and investors.
Strategic partnerships between institutions, biotech companies, and investors.
We recognize the intricate dance between pioneering science and the necessity of robust funding—an interplay where many promising ideas have faltered on the path to realization. Stem is designed as the conduit through which research meets resources, ensuring that no potential for human advancement is left unexplored due to financial constraints.
Committed to developing and upholding sustainable practices
Committed to developing and upholding sustainable practices
Committed to developing and upholding sustainable practices
We believe that the built environment plays an important role in achieving these goals
We believe that the built environment plays an important role in achieving these goals
We believe that the built environment plays an important role in achieving these goals
Committed to developing and upholding sustainable practices
Committed to developing and upholding sustainable practices
Committed to developing and upholding sustainable practices
